Cherry Thomas
Career history of Cherry Thomas
Former positions of Cherry Thomas
| Companies | Position | Start | End |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - | 01/03/2022 |
| JOUNCE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
| BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | - | - |
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | - | - |
Training of Cherry Thomas
| University of California, Los Angeles | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| University of California, Irvine | Graduate Degree |
Statistics
International
| United States | 7 |
| Cayman Islands | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| BEIGENE, LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Cherry Thomas
- Experience
